Revenue
2017
2018
2019
2020
2021
2022
2023
2024
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.07T | $3.01T | $92.0M | $103.0M | $1.92T | $2.01T | $1.85T | $1.69T | $1.72T | $1.66T |
| Operating expenses | $1.13T | $1.12T | $992.34B | $873.41B | $870.35B | $902.25B | $839.71B | $784.36B | $787.05B | $726.28B |
| Operating income | $1.58T | $1.70T | $1.74T | $1.33T | $504.85B | $771.37B | $756.59B | $681.93B | $671.25B | $688.98B |
| EBITDAderived | $1.68T | $1.79T | $1.82T | $1.41T | $578.21B | $841.91B | $794.27B | $719.47B | $706.82B | $720.80B |
| Net income | $1.25T | $1.37T | $1.45T | −$1.06T | −$401.63B | −$603.74B | −$603.63B | $572.08B | $575.05B | $609.90B |
| Basic EPSper diluted share | CLP 12.36 | CLP 13.60 | CLP 14.31 | CLP 10.46 | CLP 3.98 | CLP 5.98 | CLP 5.98 | CLP 5.66 | CLP 5.69 | CLP 6.13 |
| Diluted EPSper diluted share | CLP 12.36 | CLP 13.60 | CLP 14.31 | CLP 10.46 | CLP 3.98 | CLP 5.98 | CLP 5.98 | CLP 5.66 | CLP 5.69 | CLP 6.13 |